Abstract
This review focuses on current options in the medical therapy of metastasized urothelial carcinoma of the bladder. Standard treatments as well as new, recently published therapeutic approaches are evaluated and discussed.
| Translated title of the contribution | Systemic therapy of metastatic bladder cancer |
|---|---|
| Original language | German |
| Journal | Urologe - Ausgabe A |
| Volume | 52 |
| Issue number | 11 |
| Pages (from-to) | 1541-1546 |
| Number of pages | 6 |
| ISSN | 0340-2592 |
| DOIs | |
| Publication status | Published - 11.2013 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Research Areas and Centers
- Research Area: Luebeck Integrated Oncology Network (LION)
Fingerprint
Dive into the research topics of 'Systemic therapy of metastatic bladder cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver